LexDanaLexDanabeta
Inventor

GENNADY GOLOLOBOV

Inventor
US

Overview

3→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
C12NMicroorganisms or enzymes25%
PatentTitleYear
12,240,906Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)202511,643,463Monoclonal antibodies to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)202311,414,487Monoclonal antibodies to programmed death 1 (PD-1)2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to CSTONE PHARMACEUTICALS (1)· patent assignee history
2022Patents assigned to CSTONE PHARMACEUTICALS SHANGHAI CO LTD (1)· patent assignee history
2022Patents assigned to CSTONE PHARMACEUTICALS SUZHOU CO LTD (1)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to WUXI BIOLOGICS SHANGHAI CO LTD (2)· patent assignee history
2023Patents assigned to WUXI BIOLOGIES SHANGHAI CO LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
WUXI BIOLOGICS SHANGHAI CO LTD22023–2025
CSTONE PHARMACEUTICALS12022
CSTONE PHARMACEUTICALS SHANGHAI CO LTD12022
CSTONE PHARMACEUTICALS SUZHOU CO LTD12022
WUXI BIOLOGIES SHANGHAI CO LTD12023
Locations
LocationPatentsSpan
US32022–2025